US Patent 8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
Patent 8188296 was granted and assigned to GE Healthcare on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+418 characters)
Article
Patent abstract
The present invention relates to stabilized 123I-labelled radiopharmaceutical compositions having a stabilizer which comprises gentisic acid or a salt thereof with a biocompatible cation. Methods of preparation of the stabilized radioiodine compositions as well as the use of gentisic acid to stabilize 123I-labelled radiopharmaceutical at a specified radioactive concentration range are also described.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jan Van Den Bos0
Ton Janssen0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08188296 Gentisic acid for stabilising 123-I radiopharmaceuticals US Patent 8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
Infobox
Patent Number
081882960
Patent Number
81882960
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081882960
Date of Patent
May 29, 2012
0Patent Application Number
119952220
Date Filed
March 31, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08188296
Date of patent
May 29, 2012
Patent application number
11995222
Date Filed
March 31, 2006
Patent primary examiner
Find more entities like US Patent 8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
